In early December 2025, Recursion Pharmaceuticals released clinical data from the TUPELO Phase 1b/2 trial of REC-4881, providing fresh insight into the candidate’s safety and efficacy profile. This ...
Dec 8 (Reuters) - Recursion Pharma (RXRX.O), opens new tab, which uses artificial intelligence to discover new drug candidates, said on Monday its experimental oral drug helped reduce abnormal growths ...
December 5, 2025 • Dove Ellis. Melody's Echo Chamber. Editors' Tom Smith. Erin Wolf of Radio Milwaukee joins Stephen Thompson to discuss those albums and more on our last episode of New Music Friday ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback